Business · 12/07/1994Updated: 10/16/2026 · 1 min read
Sandoz Pharmaceuticals Corp., et al.; Withdrawal of Approval of 7 Abbreviated Antibiotic Applications and 11 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 18 applications, including 7 abbreviated antibiotic applications and 11 abbreviated new drug applications, as the holders of these applications have notified the agency that the drug products are no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →